Inflammation is a silent killer
According to the CDC, 8 out of 10 cardiac events and deaths can be prevented. Early risk assessment is key for prevention.
We need a better way to identify chronic inflammation early – because underlying inflammation (often currently undiagnosed) is a serious problem leading to many chronic disease states, including:
•Alzheimer's and other dementias
Gamma Dx is on a mission to shine a light on inflammation
Driven commercial leader, with 20+ years of healthcare industry expertise, building best-in-class sales and marketing teams globally, broad experience in commercial execution and international channel management.
41 years of research in the areas of hemostasis, thrombosis and blood coagulation, 27 years as a Principal Investigator; Professor of Surgery, Department of Surgery, Division of Trauma, Critical Care and Acute Care Surgery, Oregon Health & Science University.
25 years+ international experience in deal making, finance, value creation, business development, risk management and problem solving across diverse Industries.
Diverse expertise in the pharmaceutical and biotech industries including clinical research, KOL strategy, marketing and sales. Demonstrated history of powerful performance across multiple therapeutic areas.
Expert in the clinical diagnostic industry, including writing CLSI standards. Director of Clinical Chemistry and Toxicology at Oregon Health & Science University Hospital.
It gives me great pleasure to announce the appointment of our new Chief Executive Officer, Ajay Nair.
Ajay is an entrepreneurial and driven commercial leader, with 20+ years of medical device and healthcare industry expertise. He has worked for a number of Fortune 500 companies, most notably Johnson and Johnson, Covidien, Medtronic and Eli Lilly and held international leadership roles in Asia since 2011. He worked for several years in the prosthetics industry (an area he's deeply passionate about) and within the diagnostics space, he was the General Manager of the Greater Asia region for Leica Biosystems.
He has a Bachelors in Bioengineering from Arizona State University and a Masters in International Business from the Thunderbird Global School of Management (now a part of ASU). His expertise in building and leading world class sales organizations and marketing teams, with specialty in both start-up and scaled growth stages is exactly what Gamma Diagnostics Inc. (formerly Gamma Therapeutics Inc.) needs at this juncture.
Please join me in welcoming Ajay Nair to the team - David Farrell, Founder and Chief Scientific Officer
Want to learn more about Gamma Diagnostics? Contact us below: